Avanir Pharmaceuticals (United States)

Recent papers from Avanir Pharmaceuticals (United States)

1. Demographics and Comorbidities of Patients With Narcolepsy: A Propensity Score–Matched Cohort Study (P6-14.010)Neurology · 2026
2. Long-term Safety and Efficacy of Extended-release Once-nightly Sodium Oxybate for Narcolepsy in Patients not Currently Taking an Oxybate (P6-14.004)Neurology · 2026
3. Demographics and Disease Characteristics Among Pediatric Patients With Narcolepsy (P9-14.008)Neurology · 2026
4. Once-nightly Sodium Oxybate Improves Symptoms in People With Narcolepsy: Interim Results From the Real-world REFRESH Study (P6-14.007)Neurology · 2026
5. Thiazole-Linked N -Hydroxypropanamide Derivatives: Selective HDAC6 Inhibitors with Therapeutic Potential for Neurodegenerative DiseasesJournal of Medicinal Chemistry · 2026
6. 0700 Relative Prevalence of Narcolepsy Type 1, Narcolepsy Type 2, and Idiopathic Hypersomnia: A Claims Database AnalysisSLEEP · 2026
7. 0705 Treatment Access for Narcolepsy Across Patient Demographic Characteristics: A Claims Database AnalysisSLEEP · 2026
8. 0182 Deriving Lexicon from Community Word Usage: A Social Listening Analysis of “Brain Fog” in Central Disorders of HypersomnolenceSLEEP · 2026
9. 0766 Real-World Experience of Once-Nightly Sodium Oxybate Treatment in People with Narcolepsy: Final Results from REFRESHSLEEP · 2026
10. 0757 Sleepiness Improvement With Once-Nightly Sodium Oxybate in Patients With and Without Prior Twice-Nightly Oxybate Use: Specialty Pharmacy Data AnalysisSLEEP · 2026
11. 0764 Nighttime Symptom Experience and Treatment Challenges: Perspectives from People with NarcolepsySLEEP · 2026
12. 0722 Demographic and Clinical Characteristics of People Receiving Once-Nightly Sodium Oxybate Treatment: A Specialty Pharmacy Data AnalysisSLEEP · 2026
13. 0694 Polysomnographic Findings in Pediatric Patients with Narcolepsy Type 1 and Narcolepsy Type 2: A Retrospective ReviewSLEEP · 2026
14. 0752 Once-Nightly Sodium Oxybate Improves Symptoms in People with Narcolepsy: Final Results from the Real-World REFRESH StudySLEEP · 2026
15. 0751 Improvement in Sleepiness with Once-Nightly Sodium Oxybate in People with Narcolepsy Type 1 and Narcolepsy Type 2: A Specialty Pharmacy Data AnalysisSLEEP · 2026
16. 0693 Demographics and Disease Characteristics Among Pediatric Patients with NarcolepsySLEEP · 2026
17. 0695 Demographics and Comorbidities of Patients with Narcolepsy: A Propensity Score–Matched Cohort StudySLEEP · 2026
18. 0765 Oxybate Treatment Experience and Preferences of People with Idiopathic HypersomniaSLEEP · 2026
19. 1237 Risk Evaluation and Mitigation Strategies: From Burden to BenefitSLEEP · 2026
20. 0704 Impact of Sex and Race on Treatment of Narcolepsy: A Claims Database AnalysisSLEEP · 2026